RedHill Biopharma (RDHL) Leases (2019 - 2025)
Historic Leases for RedHill Biopharma (RDHL) over the last 7 years, with Q2 2025 value amounting to $163000.0.
- RedHill Biopharma's Leases fell 6524.52% to $163000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $163000.0, marking a year-over-year decrease of 6524.52%. This contributed to the annual value of $302000.0 for FY2024, which is 6946.41% down from last year.
- As of Q2 2025, RedHill Biopharma's Leases stood at $163000.0, which was down 6524.52% from $302000.0 recorded in Q4 2024.
- In the past 5 years, RedHill Biopharma's Leases registered a high of $7.7 million during Q1 2022, and its lowest value of $163000.0 during Q2 2025.
- Moreover, its 5-year median value for Leases was $4.2 million (2021), whereas its average is $3.9 million.
- Its Leases has fluctuated over the past 5 years, first soared by 8329.22% in 2022, then tumbled by 8522.12% in 2023.
- Over the past 5 years, RedHill Biopharma's Leases (Quarter) stood at $3.7 million in 2021, then surged by 83.29% to $6.7 million in 2022, then plummeted by 85.22% to $989000.0 in 2023, then plummeted by 69.46% to $302000.0 in 2024, then plummeted by 46.03% to $163000.0 in 2025.
- Its Leases stands at $163000.0 for Q2 2025, versus $302000.0 for Q4 2024 and $469000.0 for Q2 2024.